CXCL10 and respiratory failure: Samaras et al. have reported that GIP-10 has shown the best prognostic sensitivity in the detection of severe respiratory failure onset in COVID-19 patients among other prognostic biomarkers, including soluble urokinase plasminogen activator receptor [27], which was observed similarly in this study (Figure 1).